|

Arthritis Clinical Trials in Kansas City, MO

13 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable CancerPhase 1<1 mi
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseasePhase 4<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—<1 mi
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)Phase 2<1 mi
Nipocalimab in Moderate to Severe Sjogren's DiseasePhase 3<1 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneePhase 3<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPhase 3<1 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)Phase 3<1 mi
Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II DiabetesPhase 43 mi
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's SyndromePhase 33 mi
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease—3 mi
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 310 mi
MAD Study of IA-14069Phase 113 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.